Nabumetone

Relif 1000 MG Comprimidos Dispersables

1 g comprimido dispersableSpainMarketedAuthorised 31 May 1993

In other countries

The same active substances on other registers, the same brand first.

NabumetoneCanada · 500 MG · Tablet · Aa Pharma INCSame form
NabumetoneCanada · 500 MG · Tablet · Apotex INCSame form
Mylan-NabumetoneCanada · 500 MG · Tablet · Mylan Pharmaceuticals UlcSame form
NabuserItaly · Compressa rivestita · Pharmaday Pharmaceutical S.R.L. UnipersonaleSame form
Mebutan 1 g, tablettenNetherlands · Filmomhulde tablet · Viatris Healthcare B.V.Same form
Mebutan 500 mg, tablettenNetherlands · Filmomhulde tablet · Viatris Healthcare B.V.Same form
Mebutan Dispers 1 g, tablettenNetherlands · Tablet · Viatris Healthcare B.V.Same form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Nabumetone

Relif 1000 MG Comprimidos Dispersables

1 g comprimido dispersableSpainMarketedAuthorised 31 May 1993

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

NabumetoneUnited States · 1GM, 500MG, 750MG · tablet · Sciegen Pharms

RelafenUnited States · 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Smithkline Beecham

RelifexBrazil · Glaxosmithkline Brasil Ltda

Packs

Pack	Code	Status
RELIF 1000 MG COMPRIMIDOS DISPERSABLES , 20 comprimidos	920728

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Nabumetone
Strength: 1 g
Dosage form: comprimido dispersable
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 31 May 1993
Registration: 59395
Marketing authorisation holder: Viatris Healthcare Limited
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica